Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s room for many MASH drugs with the treatment landscape expected to shape up to include combinations of therapies bringing different approaches to this fatty liver disease. The post FDA Approval Expands Novo Nordisk’s Wegovy to the…
By MATTHEW HOLT So I am back dealing with Labcorp & Blue Shield of California over the mysterious $34 copay. If you want to catch up go here Over the weekend Labcorp sent me a final due notice on my bill…. the one that they couldn’t tell me about without asking for all the information…
Outcomes are no longer a nice-to-have or a post-hoc justification for care provided. They are a central currency of care in a system that’s shifting faster than ever toward accountability. The post For Rehab Providers Outcomes Are the Strategy: Not Just the Scorecard appeared first on MedCity News.
Here are five guidelines to help employers balance health outcomes and financial responsibility to ensure that GLP-1 coverage is effective, affordable, and aligned with improved health and workforce well-being for employees and their families. The post How Employers Can Build an Effective GLP-1 Strategy appeared first on MedCity News.
Para padres de niños en edad escolar, la lista de cosas para hacer en el otoño puede parecer interminable. Comprar útiles. Completar largos formularios. Agendar la charla con los maestros. ¿Ya les quedan chicas las zapatillas? En algún momento, puede que recuerden las vacunas contra la gripe. Vacunarte. Vacunarlos. ¿Debería hacerlo? ¿Puedo hacerlo? ¿Sigue vigente?…
Our readers play a vital role in our success. Take part in our Reader Survey and help us continue to grow! The post If You Value MedCity News, Take Our Audience Survey appeared first on MedCity News.
For parents of school-aged children, the fall to-do list can seem ever-growing. Buy school supplies. Fill out endless school forms. Block off parent-teacher nights. Do the kids’ tennis shoes still fit? Somewhere, at some point, you might remember flu shots. Get your flu shot. Get their flu shots. Or should you? Can you? Is that…
BRISTOL, R.I. — At age 82, Roberta Rabinovitz realized she had no place to go. A widow, she had lost both her daughters to cancer, after living with one and then the other, nursing them until their deaths. Then she moved in with her brother in Florida, until he also died. And so last fall,…
Hospital margins improved in June as revenue gains outpaced patient volume — but Kaufman Hall’s latest data shows that financial gaps between high- and low-performing organizations persist, with increasing expenses and bad debt threatening long-term stability. The post Hospital Margins Grow, Yet Bad Debt & Expenses Continue to Climb appeared first on MedCity News.
Noom recently launched a microdosing program for GLP-1s. However, some are concerned about the use of compounded GLP-1s in this program, as they are not FDA-approved. The post GLP-1s Come With High Price Tags and Major Side Effects. Could Microdosing Be the Answer? appeared first on MedCity News.